Cite this asNachimuthu S, Senthil K, Ramalingam M (2019) Large Prostatic Calculus in an Alkaptonuria patient – Caught unaware. J Surg Surgical Res 5(1): 045-046. DOI: 10.17352/2455-2968.000069
Alkaptonuria, a metabolic disorder with urological manifestation goes unnoticed till we are aware of it. Here we present an alkaptonuric patient with difficult catheterisation was diagnosed with a large prostatic calculus and his management.
Alkaptonuria is a rare inherited metabolic disorder involving the serum homogentisic acid levels. Most of the people affected have varied presentations. Very rarely genitourinary system is involved. Prostatic calculi and black coloured urine are the urological presentations of this condition.
55 years old male a known case of Alkaptonuria, recently underwent left hip replacement surgery. He developed urinary retention just after surgery. Per urethral catheterisation was attempted but could not be passed and hence cystoscopy was done. To our surprise cystoscopy showed a calculus in prostatic fossa that could not be pushed back into bladder and suprapubic catheterisation (SPC) was done. Xray Pelvis revealed speckled calcification behind pubic symphysis. Cystolitholapaxy was planned electively (Figure 1 ). Cystoscopy after 3 weeks revealed large prostatic urethral calculus of size of 2.5cms. As the stone could not be pushed into urinary bladder, it was fragmented with laser energy in prostatic fossa into small fragments. After 120 minutes of fragmentation, the fragments were pushed into bladder and washed out. Patient had a stable post operative period. Stone fragments were analysed which showed bilirubin and cholesterol. His urine was positive for alkaptonuria. Xray spine revealed multilevel intervertebral disc calcification with severe narrowing of the intervertebral disc spaces and associated anterior osteophyes along the lumbar vertebrae. His catheters were removed on POD 5 and was voiding with Qmax of 15ml/sec.
Alkaptonuria is a rare metabolic disorder first described by Sir Archibald Edward Garrod; who first used the expression, ‘inborn errors of metabolism’, to describe four rare disorders - alkaptonuria, albinism, cystinuria and pentosuria. He discovered that such disorders resulted from enzymatic defects in the catabolic pathways of aminoacids and sugars [1,2]. Autosomal recessive mutations of the homogentisic acid (HGA)oxidase gene, located on human chromosome 3q 21-q 23, results in a defect in the metabolism of homogentisic acid . There is accumulation of homogentisic acid in patients with alkaptonuria. Oxidation of this acid leads to formation of a blackish melanin like pigment which is selectively deposited in the connective tissue and cartilage. Though pediatric alkaptonuria is rare, it has been reported. Generally symptoms become apparent around third to fourth decade. The common clinical presentation for alkaptonuria include pigmentation of the sclera, pinnae and nasal ala; musculoskeletal abnormalities like narrowing of the joint spaces, cartilage degeneration and the calcifications of the disc leading to loss of lumbar lordosis; exaggerated thoracic kyphosis, ankylosis and loss of height; change of the color of the urine to black on exposure to air, renal and prostatic calculi; cardiac valve calcification and stenosis .
Urine excretion of homogentisic acid (alkapton) is very high and has high propensity for stone formation [2,3]. Very rarely alkaptonuria patients end up in renal failure. There have been similar reports of prostatic calculi and alkaptonuria in the past [4,5], with the detection of majority of the prostatic calculi being either incidental or with lower urinary tract symptoms. Prostatolithiasis in alkaptonuria is of two types - true prostatolithiasis with deposition of calculi in the prostatic gland and false prostatolithiasis with the location of calculi being in pars prostatica urethrae . In our case the calculus was in the pars prostatica. The formation of calculi is secondary to the accumulation of homogentisic acid which precipitates the deposition of crystals. The composition of the prostatic and renal calculi is usually the standard constituents such as calcium oxalate monohydrate and dihydrate , but in our case it was bilirubin and cholestrol which again is very unusual. Symptomatic prostatic calculi in alkaptonuria has been reported is limited to a similar case report where the patient presented with features of chronic prostatitis  and was managed conservatively.
The patient discussed had cutaneous manifestations like ochronosis in the palms and sclera which were asymptomatic (Figure 2) similar to a case report , where patient had a hard prostate mimicking carcinoma but had extensive calculi deposition. Our patient had bothersome lower urinary tract symptoms due to large prostatic calculus but was not on treatment till he had to be catheterised in post operative period. Homogentisic acid in urine was positive to confirm the diagnosis. He was relieved of his symptoms after the removal of the prostatic calculus. Similar case reports [8,9], have been published who were managed successfully with enodurological procedures.
There are therapeutic options for patients who have been diagnosed with alkaptonuria like dietary restriction of protein, vitamin c supplementation but are not usually effective. Nitisinone a herbicide, inhibits 4- hydroxy phenyl pyruvate dioxygenase and decreases the formation of homogentisic acid. Nitisinone therapy may effectively reduce HGA levels. In addition to long term monitoring for efficacy and safety, it also requires lifelong treatment. Only symptomatic management is presently available and periodic evaluation of bone and joints, kidney, prostate and cardiac complications is advisable .
This rare case highlights the need for suspicion of prostatic calculus in an alkapatonuria patient and role for surgical management in such cases. To our knowledge this is the first report of surgical laser lithotripsy in-situ of a large alkaptonuric calculus in the prostatic urethra.
Subscribe to our articles alerts and stay tuned.